Lv1
40 积分 2025-03-04 加入
Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Biomarker in Advanced Hepatocellular Carcinoma Treated with First-Line Immunotherapy
3天前
已完结
ongterm outcome of hepatectomy following conversion therapy for initially unresectable hepatocellular carcinoma versus direct hepatectomy for early-stage hepatocellular carcinoma
24天前
已完结
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases
1个月前
已完结
Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH
1个月前
已完结
Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review
1个月前
已完结
Perioperative Considerations in the Management of Anticoagulation Therapy for Patients Undergoing Surgery
1个月前
已完结
Trajectories of postoperative hepatitis B virus (HBV) DNA and HBV-related hepatocellular carcinoma outcomes
1个月前
已完结
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
1个月前
已完结
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab
1个月前
已完结
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
1个月前
已完结
皖公网安备34019202002308
